Cipla ready to launch low-dose Efavirenz 400 mg

Read more

Experts address impact of M&A in pharma

Read more

JP Nadda lays foundation stone for advanced research centre in Ghaziabad

Read more

India Pharma 2016 to be held from January 7-9, 2016

Read more

Sifting the trends into 2016

Read more

Cipla inks investment pact with FIL Capital Investment

Read more

Merck plans to sell its allergy business unit to cut debt

Read more

TAKE Solutions names Raman Kapur as Independent Director

Read more

Sales rep files sexual harassment claims against DRL, Promius Pharma

Read more

US FDA warns of serious data integrity violations at DRL

Read more